# molecular-synthetic-genomics-pipeline
A proof-of-concept synthetic genomics workflow for variant prioritization, rare-variant burden testing, GWAS-style fine-mapping, and patient stratification.

# Molecularly Informed Synthetic Genomics Pipeline

A proof-of-concept genomics workflow that simulates a rare- and complex-disease analysis pipeline, from variant annotation and prioritization to rare-variant burden testing, GWAS-style locus discovery, fine-mapping, and patient stratification.

## Overview

This repository contains a synthetic, molecularly informed genomics pipeline designed to demonstrate how modern genomic data science connects DNA variation to molecular function, cohort structure, and disease-oriented inference. The project uses simulated data rather than real patient genomes, but it is built to reflect realistic analytical logic and biologically plausible patterns.

The workflow integrates five major layers of analysis:

1. **Variant annotation and prioritization**  
   Simulates coding and noncoding variants, assigns molecular consequences, and ranks candidate pathogenic variants using features such as allele frequency, conservation, splice impact, and integrated deleteriousness.

2. **Population-aware cohort structure**  
   Generates a synthetic multi-ancestry cohort and uses principal component analysis to recover broad ancestry-related structure.

3. **Rare-variant burden analysis**  
   Aggregates rare damaging variants at the gene level to test for case‚ control enrichment in a rare disease-like phenotype.

4. **GWAS-style common variant analysis and fine-mapping**  
   Simulates a common-variant locus, performs variant-level association testing, and uses a Bayesian-style fine-mapping step to prioritize the most likely causal signal.

5. **Patient-level feature integration**  
   Combines genomic burden and phenotype features into a low-dimensional embedding to illustrate partial disease-related structure.

## Repository contents

- `genomics_molecular_proof_of_concept.ipynb`  
  Main executable notebook containing the full synthetic workflow, commentary cells, figures, and result tables.

- `README.md`  
  Project overview, structure, usage, and interpretation guide.

- `modelcard.md`  
  Documentation describing the variant prioritization model, intended use, inputs, outputs, strengths, and limitations.

- `datasheet.md`  
  Documentation describing the synthetic datasets used in the notebook, how they were generated, and how they should be interpreted.

- `gene_burden_results.csv`  
  Gene-level burden testing results for rare damaging variants in the synthetic rare disease-like phenotype.

- `gwas_finemap_results.csv`  
  Variant-level association and fine-mapping summary across the synthetic common-variant locus.

- `synthetic_cohort_preview.csv`  
  Preview table showing representative individual-level ancestry, phenotype, and burden-related features.

- `top_prioritized_variants.csv`  
  Ranked list of top candidate variants from the synthetic prioritization workflow.

## Scientific motivation

Human genomic analysis is a multi-scale problem. A DNA variant may alter a codon, disrupt splicing, change transcript structure, reduce protein abundance, or impair protein function. At the same time, the observed importance of that variant depends on evolutionary constraint, allele frequency, ancestry background, and disease context.

This repository was built to show, in one coherent workflow, how genomic data science moves from:

- sequence variation,
- to molecular annotation,
- to statistical prioritization,
- to gene- and locus-level inference,
- to patient-level interpretation.

## What this repository is and is not

This repository **is**:

- a proof-of-concept,
- a portfolio-quality genomics workflow,
- a teaching and demonstration resource,
- a synthetic framework for explaining end-to-end genomic analysis.

This repository **is not**:

- a clinically validated diagnostic pipeline,
- a substitute for ACMG/AMP clinical interpretation,
- an analysis of real patient data,
- a benchmarked production workflow for regulated use.

## Methods summary

The pipeline includes the following major steps:

- simulation of a synthetic variant panel with a rare-variant‚Äìenriched allele-frequency spectrum,
- assignment of molecular consequence classes,
- generation of annotation-style features such as CADD-like, REVEL-like, phyloP-like, and SpliceAI-like scores,
- simulation of read depth and call rate for quality control,
- principal component analysis of synthetic genotype features,
- supervised pathogenic-versus-benign variant prioritization,
- simplified research-side interpretation classes,
- rare damaging burden aggregation at the gene level,
- GWAS-style association testing across a synthetic locus,
- Bayesian-style fine-mapping using posterior inclusion probabilities,
- low-dimensional embedding of individuals using burden and phenotype features.

## Key outputs

The notebook produces:

- allele-frequency spectrum plots,
- depth versus call-rate quality-control plots,
- molecular consequence enrichment plots,
- ancestry principal component plots,
- ROC and precision‚Äìrecall curves,
- feature importance summaries,
- simplified interpretation class summaries,
- burden analysis plots,
- GWAS-style locus plots,
- fine-mapping posterior plots,
- patient embedding plots,
- summary tables for variants, genes, loci, and cohort features.

## How to run

### Requirements

Recommended Python environment:

- Python 3.10+
- numpy
- pandas
- matplotlib
- scikit-learn
- scipy
- jupyter

### Run steps

1. Open the notebook:
   `genomics_molecular_proof_of_concept.ipynb`

2. Run all cells from top to bottom.

3. Review generated figures, tables, and exported CSV files.

## Interpreting the outputs

A few guiding principles:

- **Rare does not automatically mean pathogenic.**  
  Rare variants are often more suspicious, but pathogenicity also depends on molecular effect and biological context.

- **Loss-of-function classes are enriched, not uniformly causal.**  
  Splice donor, stop-gained, and frameshift variants are more likely to be damaging, but interpretation still requires evidence integration.

- **Population structure matters.**  
  Ancestry-related variation can confound analyses if it is ignored.

- **Association is not causation.**  
  GWAS-style signals identify statistical relationships, while fine-mapping narrows candidate variants probabilistically.

- **Patient clustering is rarely perfect.**  
  Disease-relevant biology often forms overlapping patterns rather than fully separated groups.

## Limitations

- All data are simulated.
- Molecular annotations are synthetic proxies, not real measured annotations.
- The interpretation framework is simplified and not suitable for clinical decision-making.
- Rare-variant burden results depend strongly on simulation settings.
- Fine-mapping is implemented as a lightweight proof-of-concept rather than a full production framework.

## Intended audience

This repository may be useful for:

- genomic data scientist,
- demonstrations,
- teaching genomics workflows,
- explaining rare- and complex-disease analysis,
- early-stage prototyping of integrated genomic pipelines.

## Suggested citation

If you refer to this repository, describe it as:

**Petalcorin, M.I.R.** (2026). **A molecularly informed synthetic genomics proof-of-concept pipeline for variant prioritization, rare-variant burden testing, fine-mapping, and patient stratification.** https://github.com/mpetalcorin/molecular-synthetic-genomics-pipeline
